300049 Stock Overview
Inner Mongolia Furui Medical Science Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Inner Mongolia Furui Medical Science Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥35.27 |
| 52 Week High | CN¥57.50 |
| 52 Week Low | CN¥28.73 |
| Beta | -0.25 |
| 1 Month Change | -11.83% |
| 3 Month Change | -2.57% |
| 1 Year Change | -16.48% |
| 3 Year Change | 169.85% |
| 5 Year Change | 369.64% |
| Change since IPO | 247.66% |
Recent News & Updates
Here's Why We Think Inner Mongolia Furui Medical Science (SZSE:300049) Might Deserve Your Attention Today
Dec 18
Subdued Growth No Barrier To Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049) With Shares Advancing 35%
Oct 17Recent updates
Here's Why We Think Inner Mongolia Furui Medical Science (SZSE:300049) Might Deserve Your Attention Today
Dec 18Subdued Growth No Barrier To Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049) With Shares Advancing 35%
Oct 17Here's Why We Think Inner Mongolia Furui Medical Science (SZSE:300049) Might Deserve Your Attention Today
Sep 02Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) Intrinsic Value Is Potentially 30% Above Its Share Price
Jul 21With EPS Growth And More, Inner Mongolia Furui Medical Science (SZSE:300049) Makes An Interesting Case
May 24We Think Inner Mongolia Furui Medical Science (SZSE:300049) Can Manage Its Debt With Ease
Apr 29Investors Still Waiting For A Pull Back In Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049)
Feb 28Shareholder Returns
| 300049 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.5% | -4.3% | -3.5% |
| 1Y | -16.5% | -3.4% | 10.9% |
Return vs Industry: 300049 underperformed the CN Pharmaceuticals industry which returned -3.4% over the past year.
Return vs Market: 300049 underperformed the CN Market which returned 10.9% over the past year.
Price Volatility
| 300049 volatility | |
|---|---|
| 300049 Average Weekly Movement | 11.1% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300049's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300049's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 703 | Guanyi Wang | www.fu-rui.com |
Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. It operates in two segments, pharmaceutical production and sales; and diagnostic equipment R&D, production and sales.
Inner Mongolia Furui Medical Science Co., Ltd. Fundamentals Summary
| 300049 fundamental statistics | |
|---|---|
| Market cap | CN¥9.38b |
| Earnings (TTM) | CN¥130.40m |
| Revenue (TTM) | CN¥1.33b |
72.0x
P/E Ratio7.1x
P/S RatioIs 300049 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300049 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.33b |
| Cost of Revenue | CN¥335.03m |
| Gross Profit | CN¥991.56m |
| Other Expenses | CN¥861.16m |
| Earnings | CN¥130.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.49 |
| Gross Margin | 74.74% |
| Net Profit Margin | 9.83% |
| Debt/Equity Ratio | 0% |
How did 300049 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 22:42 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Inner Mongolia Furui Medical Science Co., Ltd. is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Chen He | Chasing Securities |
| Shitong Han | Citic Securities Co., Ltd. |
| Siao Ye | Everbright Securities Co. Ltd. |